In recent news, there has been a three-way merger announced between Fresenius Health Partners, InterWell Health, and Cricket Health. This merger is set to create the nation's premier value-based kidney care provider under the name of the new InterWell Health. With a separate board of directors and a mission to expand and improve kidney care, this new entity aims to revolutionize the way we approach value-based care for patients with kidney diseases.

Ben H.

Ben H.

Nov 16, 20233 min read

0

In recent news, there has been a three-way merger announced between Fresenius Health Partners, InterWell Health, and Cricket Health. This merger is set to create the nation's premier value-based kidney care provider under the name of the new InterWell Health. With a separate board of directors and a mission to expand and improve kidney care, this new entity aims to revolutionize the way we approach value-based care for patients with kidney diseases.

One of the key strengths that Fresenius Health Partners brings to the new InterWell Health is their expertise in value-based contracting and performance. With their experience in this area, they have been able to work directly with InterWell Health since 2019 to form a network of over 1,600 nephrologists. This network has successfully reduced hospitalizations and readmissions, leading to significant savings for payor partners. By combining the resources and knowledge of both organizations, the new InterWell Health will be able to further enhance these results and provide even better care for patients.

Another exciting aspect of the new InterWell Health is the incorporation of Cricket Health's machine learning and predictive analytics capabilities. This technology will play a crucial role in facilitating improved engagement and earlier intervention for patients. By leveraging these advanced analytics, InterWell Health will be able to identify potential issues before they become major problems, allowing for timely intervention and improved outcomes. This integration of technology into kidney care is a significant step forward in the field and has the potential to revolutionize the way we approach patient care.

As we look towards the future of kidney care, it is essential to recognize the unique opportunity that the new InterWell Health presents. By combining the strengths of multiple organizations, they have the potential to transform value-based kidney care and improve outcomes for patients. However, it is not enough to rely solely on mergers and technology. There are actionable steps that both healthcare providers and patients can take to ensure the best possible care.

Firstly, healthcare providers should focus on building strong physician leadership within their organizations. By having physicians who are knowledgeable and passionate about kidney care, they can drive innovation and improvements in patient outcomes. This can be achieved through ongoing education and training programs, as well as providing opportunities for physicians to take on leadership roles within the organization.

Secondly, patients should take an active role in their own kidney care. This includes being proactive in seeking regular check-ups and screenings, as well as following any prescribed treatments or medications. Staying informed about the latest advancements in kidney care and advocating for oneself can make a significant difference in overall health outcomes.

Lastly, policymakers and regulatory bodies should prioritize value-based care and provide support for organizations like the new InterWell Health. By incentivizing and promoting value-based contracting and performance, they can encourage more healthcare providers to adopt this approach, leading to improved outcomes and cost savings. Additionally, investing in research and development for innovative technologies and treatments can further advance the field of kidney care.

In conclusion, the merger of Fresenius Health Partners, InterWell Health, and Cricket Health to form the new InterWell Health presents a unique opportunity to transform value-based kidney care. With the expertise in value-based contracting, strong physician leadership, and innovative technology, this new entity is poised to make a significant impact in the field. By taking actionable steps to build strong physician leadership, empower patients, and support value-based care, we can further enhance the outcomes for patients with kidney diseases. The future of kidney care looks promising, and it is up to all stakeholders to work together to drive positive change.

Resource:

  1. "The New InterWell Health – A Unique Opportunity to Transform Value Based Kidney Care", https://fmcna.com/insights/articles/new-interwell-health/ (Glasp)
  2. "The Role of Pharmacy Benefit Managers in Prescription Drug Markets Part II: Not What the Doctor Ordered - United States House Committee on Oversight and Accountability", https://oversight.house.gov/hearing/the-role-of-pharmacy-benefit-managers-in-prescription-drug-markets-part-ii-not-what-the-doctor-ordered/ (Glasp)

Want to hatch new ideas?

Glasp AI allows you to hatch new ideas based on your curated content. Let's curate and create with Glasp AI :)